BAXTER INTERNATIONAL INC. Revenue
BAXTER INTERNATIONAL INC. (BAX) reported Revenue of $2.96 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $2.96B, a 5.34% increase year-over-year.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $2.70B, a 2.90% increase year-over-year.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $2.97B, a 8.03% increase year-over-year.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $2.83B, a 5.04% increase year-over-year.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $11.24B, a 5.72% increase from fiscal 2024.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $10.64B, a 2.66% increase from fiscal 2023.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $10.36B, a 3.01% increase from fiscal 2022.
- BAXTER INTERNATIONAL INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $10.06B, a 17.20% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.96B 10-Q · filed 2026-07-30 | $5.66B 10-Q · filed 2026-07-30 | $8.63B derived: sum of 3 quarters · filed 2026-07-30 | $11.47B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $2.70B 10-Q · filed 2026-04-30 | $5.67B derived: sum of 2 quarters · filed 2026-04-30 | $8.51B derived: sum of 3 quarters · filed 2026-04-30 | $11.32B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $2.97B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $5.81B derived: sum of 2 quarters · filed 2026-02-12 | $8.62B derived: sum of 3 quarters · filed 2026-07-30 | $11.24B 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $2.83B 10-Q · filed 2025-11-04 | $5.64B derived: sum of 2 quarters · filed 2026-07-30 | $8.27B 10-Q · filed 2025-11-04 | $11.02B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $2.81B 10-Q · filed 2026-07-30 | $5.43B 10-Q · filed 2026-07-30 | $8.19B derived: sum of 3 quarters · filed 2026-07-30 | $10.89B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $2.63B 10-Q · filed 2026-04-30 | $5.38B derived: sum of 2 quarters · filed 2026-04-30 | $8.08B derived: sum of 3 quarters · filed 2026-04-30 | $10.77B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $2.75B 10-K · filed 2025-02-21 | $5.45B derived: sum of 2 quarters · filed 2025-11-04 | $8.15B derived: sum of 3 quarters · filed 2025-11-04 | $10.64B 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $2.70B 10-Q · filed 2025-11-04 | $5.39B derived: sum of 2 quarters · filed 2025-11-04 | $7.88B 10-Q · filed 2025-11-04 | $10.61B derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $2.69B 10-Q · filed 2025-08-05 | $3.81B 10-Q · filed 2024-08-06 | $5.18B 10-Q · filed 2025-08-05 | $7.40B 10-Q · filed 2024-08-06 | $7.91B derived: sum of 3 quarters · filed 2025-08-05 | $10.51B derived: sum of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | $2.49B 10-Q · filed 2025-05-06 | $3.59B 10-Q · filed 2024-05-02 | $5.22B derived: sum of 2 quarters · filed 2025-05-06 | $7.82B derived: sum of 3 quarters · filed 2025-05-06 | $10.41B derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $2.73B 10-K · filed 2025-02-21 | $3.88B 10-K · filed 2024-02-08 | $5.33B derived: sum of 2 quarters · filed 2025-02-21 | $7.92B derived: sum of 3 quarters · filed 2025-02-21 | $10.36B 10-K · filed 2026-02-12 | $14.81B 10-K · filed 2024-02-08 | ||
| 2023-09-30 | $2.60B 10-K · filed 2025-02-21 | $3.71B 10-Q · filed 2023-11-02 | $5.19B derived: sum of 2 quarters · filed 2025-02-21 | $7.63B 10-Q · filed 2024-11-12 | $10.93B 10-Q · filed 2023-11-02 | $11.38B derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2023-06-30 | $2.59B 10-K · filed 2025-02-21 | $3.71B 10-Q · filed 2023-07-27 | $7.22B 10-Q · filed 2024-08-06 | $8.78B derived: sum of 3 quarters · filed 2025-02-21 | $12.39B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | $2.44B 10-K · filed 2025-02-21 | $3.65B 10-Q · filed 2023-04-27 | $6.19B derived: sum of 2 quarters · filed 2025-02-21 | $9.79B derived: sum of 3 quarters · filed 2025-02-21 | $13.39B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | $3.75B 10-K · filed 2024-02-08 | $7.35B derived: sum of 2 quarters · filed 2024-02-08 | $10.95B derived: sum of 3 quarters · filed 2024-02-08 | $10.06B 10-K · filed 2025-02-21 | $15.11B 10-K · filed 2023-02-09 | |||
| 2022-09-30 | $3.61B 10-K · filed 2024-02-08 | $3.77B 10-Q · filed 2022-10-27 | $7.20B derived: sum of 2 quarters · filed 2024-02-08 | $10.76B 10-Q · filed 2023-11-02 | $11.23B 10-Q · filed 2022-10-27 | $13.64B derived: sum of 4 quarters · filed 2024-02-08 | ||
| 2022-06-30 | $3.59B 10-K · filed 2024-02-08 | $3.75B 10-Q · filed 2022-07-28 | $7.15B 10-Q · filed 2023-07-27 | $7.45B 10-Q · filed 2022-07-28 | $10.03B derived: sum of 3 quarters · filed 2024-02-08 | $13.25B derived: sum of 4 quarters · filed 2024-02-08 | ||
| 2022-03-31 | $3.56B 10-K · filed 2024-02-08 | $3.71B 10-Q · filed 2022-04-28 | $6.43B derived: sum of 2 quarters · filed 2024-02-08 | $9.66B derived: sum of 3 quarters · filed 2024-02-08 | $12.76B derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2021-12-31 | $2.88B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $6.10B derived: sum of 2 quarters · filed 2024-02-08 | $9.20B derived: sum of 3 quarters · filed 2024-02-08 | $12.15B 10-K · filed 2024-02-08 | $12.78B 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $3.23B 10-Q · filed 2022-10-27 | $6.32B derived: sum of 2 quarters · filed 2022-10-27 | $9.27B 10-Q · filed 2022-10-27 | $12.45B derived: sum of 4 quarters · filed 2022-10-27 | ||||
| 2021-06-30 | $3.10B 10-Q · filed 2022-07-28 | $6.04B 10-Q · filed 2022-07-28 | $9.22B derived: sum of 3 quarters · filed 2022-07-28 | $12.20B derived: sum of 4 quarters · filed 2022-07-28 | ||||
| 2021-03-31 | $2.95B 10-Q · filed 2022-04-28 | $6.13B derived: sum of 2 quarters · filed 2022-04-28 | $9.10B derived: sum of 3 quarters · filed 2022-04-28 | $11.82B derived: sum of 4 quarters · filed 2022-04-28 | ||||
| 2020-12-31 | $3.18B 8-K · filed 2021-04-29 | $6.15B derived: sum of 2 quarters · filed 2021-10-28 | $8.87B derived: sum of 3 quarters · filed 2021-10-28 | $11.67B 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $2.97B 10-Q · filed 2021-10-28 | $5.69B derived: sum of 2 quarters · filed 2021-10-28 | $8.49B 10-Q · filed 2021-10-28 | $11.53B derived: sum of 4 quarters · filed 2021-10-28 | ||||
| 2020-06-30 | $2.72B 10-Q · filed 2021-07-29 | $5.52B 10-Q · filed 2021-07-29 | $8.56B derived: sum of 3 quarters · filed 2021-07-29 | $11.41B derived: sum of 4 quarters · filed 2021-07-29 | ||||
| 2020-03-31 | $2.80B 10-Q · filed 2021-04-29 | $5.84B derived: sum of 2 quarters · filed 2021-04-29 | $8.69B derived: sum of 3 quarters · filed 2021-04-29 | $11.53B derived: sum of 4 quarters · filed 2021-04-29 | ||||
| 2019-12-31 | $3.04B 8-K · filed 2021-04-29 | $5.89B derived: sum of 2 quarters · filed 2021-04-29 | $8.72B derived: sum of 3 quarters · filed 2021-04-29 | $11.36B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $2.85B 8-K · filed 2021-04-29 | $5.68B derived: sum of 2 quarters · filed 2021-04-29 | $8.32B 10-Q · filed 2020-10-29 | $11.16B derived: sum of 4 quarters · filed 2021-04-29 | ||||
| 2019-06-30 | $2.83B 8-K · filed 2021-04-29 | $2.84B 10-Q · filed 2019-07-30 | $5.47B 10-Q · filed 2020-07-30 | $8.30B derived: sum of 3 quarters · filed 2021-04-29 | $11.07B derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2019-03-31 | $2.64B 8-K · filed 2021-04-29 | $2.63B 10-Q · filed 2019-05-08 | $5.47B derived: sum of 2 quarters · filed 2021-04-29 | $8.23B derived: sum of 3 quarters · filed 2021-04-29 | $11.04B derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2018-12-31 | $2.83B 10-K · filed 2020-03-17 | $2.84B 10-K · filed 2019-02-21 | $5.59B derived: sum of 2 quarters · filed 2020-03-17 | $8.41B derived: sum of 3 quarters · filed 2020-03-17 | $11.10B 8-K · filed 2021-04-29 | $11.13B 10-K · filed 2019-02-21 | ||
| 2018-09-30 | $2.76B 10-Q · filed 2020-03-17 | $2.77B 10-Q · filed 2018-11-05 | $5.57B derived: sum of 2 quarters · filed 2020-03-17 | $8.27B 10-Q · filed 2020-03-17 | $8.29B 10-Q · filed 2018-11-05 | $11.04B derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2018-06-30 | $2.81B 10-K · filed 2020-03-17 | $2.84B 10-Q · filed 2018-08-06 | $5.50B 10-K · filed 2020-03-17 | $5.52B 10-Q · filed 2018-08-06 | $8.28B derived: sum of 3 quarters · filed 2020-03-17 | $10.99B derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2018-03-31 | $2.69B 10-K · filed 2020-03-17 | $2.68B 10-K · filed 2019-02-21 | $5.47B derived: sum of 2 quarters · filed 2020-03-17 | $8.17B derived: sum of 3 quarters · filed 2020-03-17 | $10.78B derived: sum of 4 quarters · filed 2020-03-17 | |||
| 2017-12-31 | $2.77B 10-K · filed 2019-02-21 | $5.48B derived: sum of 2 quarters · filed 2019-02-21 | $8.09B derived: sum of 3 quarters · filed 2019-02-21 | $10.58B 10-K · filed 2020-03-17 | $10.56B 10-K · filed 2019-02-21 | |||
| 2017-09-30 | $2.71B 10-K · filed 2019-02-21 | $5.31B derived: sum of 2 quarters · filed 2019-02-21 | $7.79B 10-Q · filed 2018-11-05 | |||||
| 2017-06-30 | $2.60B 10-K · filed 2019-02-21 | $5.08B 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | $2.48B 10-K · filed 2019-02-21 | |||||||
| 2016-12-31 | $10.16B 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |